SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036120
Filing Date
2020-08-04
Accepted
2020-08-04 16:12:16
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-10q_20200630.htm   iXBRL 10-Q 2703422
2 EX-10.1 kpti-ex101_116.htm EX-10.1 67248
3 EX-31.1 kpti-ex311_8.htm EX-31.1 8116
4 EX-31.2 kpti-ex312_7.htm EX-31.2 8138
5 EX-32.1 kpti-ex321_9.htm EX-32.1 5964
6 EX-32.2 kpti-ex322_6.htm EX-32.2 6244
  Complete submission text file 0001564590-20-036120.txt   8349618

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20200630.xsd EX-101.SCH 42553
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20200630_cal.xml EX-101.CAL 46628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20200630_def.xml EX-101.DEF 167250
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20200630_lab.xml EX-101.LAB 355219
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20200630_pre.xml EX-101.PRE 274176
12 EXTRACTED XBRL INSTANCE DOCUMENT kpti-10q_20200630_htm.xml XML 1563937
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 201073415
SIC: 2834 Pharmaceutical Preparations